Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > Articles online first > The Journal of Cardiovascular Surgery 2022 Aug 01



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as


Original Article   

The Journal of Cardiovascular Surgery 2022 Aug 01

DOI: 10.23736/S0021-9509.22.12007-0


language: English

The influence of narrow aortic bifurcation on limb graft patency: a two-centre retrospective study

Wen WEN 1 , Hozan MUFTY 1, Athanasios KATSARGYRIS 2, Geert MALEUX 3, Kim DAENENS 1, Sabrina HOUTHOOFD 1, Inge FOURNEAU 1, Eric VERHOEVEN 2

1 Department of Vascular Surgery, University Hospitals Leuven, Leuven, Belgium; 2 Department of Vascular and Endovascular Surgery, General Hospital and Paracelsus Medical University, Nuremberg, Germany; 3 Department of Radiology, University Hospitals Leuven, Leuven, Belgium


BACKGROUND: Narrow aortic bifurcation (NAB) has been considered as a potential risk factor for graft limb thrombosis after endovascular aortic repair (EVAR). The aim of this study is to compare mid- and long-term outcome of EVAR in patients with NAB and standard aortic bifurcation (SAB).
METHODS: Data from patients receiving EVAR were prospectively collected and retrospectively analysed. In case of angiographic limb stenosis (>50%), additional stenting was performed. Patients with a NAB (≤20mm) were included in the NAB group, the remaining patients in the SAB group. Primary endpoints were limb thrombosis rate and technical success.
RESULTS: A total of 902 patients were included; 18.3% (N=165/902) in the NAB and 81.7% (N=737/902) in the SAB group. Mean follow-up time was 43 months (range 0-198 months). Bilateral stenting of the aortic bifurcation was performed in 2.7% (N=27/902), 8.5% (N=14/165) in the NAB and 1.4% (N=10/737) in the SAB group (P=.001). Limb thrombosis was found in 2.8% (N=25/902), 3.6% (N=6/165) in the NAB and 2.6% (N=19/737) in the SAB group (P=.55). Technical success was 97.8%, 98.8% in the NAB and 97.6% in the SAB group (P=.33). Device related reintervention rate was 16% (N=144/902), 15.2% in the NAB and 16.1% in the SAB group (P=.75).
CONCLUSIONS: Standard EVAR could safely be performed in patients with NAB (≤20mm) when a low threshold for additional stenting was applied. This resulted in no significant higher incidence of limb thrombosis. Additional stent deployment did not increase the complication rate.

KEY WORDS: Aortic aneurysm, abdominal; Endovascular procedures; Graft occlusion, vascular; Vascular patency; Reoperation; Mortality

top of page